¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed lymphocyte culture reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® stool culture ÇÑ±Û ´ëº¯ ¹è¾ç
¼³¸í   
  ´ëº¯À» ´ëº¯Åë¿¡ Àû´ç·® ´ã¾Æ º¸³»°í, Á÷Àåµµ¸»(rectal swab: Á÷Á¢ Ç×¹®¿¡¼­ ´ëº¯À» ¹¯Çô¼­ ¹Þ¾Æ³»´Â °Í)°Ëü´Â µÎ°³ÀÇ ¸éºÀÀ» ¿î¹Ý¹èÁö¿¡ ³Ö¾î º¸³½´Ù. ¸ÕÀú ±×¶÷¿°»öÇÏ¿© ¹éÇ÷±¸°¡ º¸À̴ Áö¸¦ °üÂûÇÏ°í ¹éÇ÷±¸°¡ ¸¹ÀÌ º¸À̸頴ëºÎºÐ ¼¼±Õ¼º ÀÌÁúÀÏ °¡´É¼ºÀÌ ³ô´Ù. ¹è¾ç¹æ¹ýÀº ±Õ¿¡ µû¶ó ´Ù¸£¸ç »ì¸ð³Ú¶ó(Salmonella)´Â S-S ¿ì¹«¿¡ ¹è¾çÇϸ砿»½Ã´Ï¾Æ(Yersinia)´Â CIN ¿ì¹«¿¡ ¹è¾çÇϸç, ºñºê¸®¿À(Vibrio)´Â TCBS ¿ì¹«¿¡ ¹è¾çÇϸç, Å¬·Î½ºÆ®¸®µã(Clostridium)Àº TCCF ¿ì¹«¿¡ ¹è¾çÇϸç, ÃÖ±Ù ¹ß°ßµÈ Àå¿ëÇ÷¼º ´ëÀå±Õ(EHEC)Àº sorbital MAC ¿ì¹«¿¡¼­ ¹è¾çÇÑ´Ù.
¿µ¹® lymphocyte ÇÑ±Û ¸²ÇÁ±¸
¼³¸í   
  ¸é¿ª±â´ÉÀ» ´ã´çÇϴ ¼¼Æ÷. °ñ¼ö¿¡¼­ ¸¸µé¾îÁö¸ç, ¸²ÇÁ±¸´Â Å©°Ô 2°¡Áö·Î ´ëºÐµÈ´Ù. À̸¥¹Ù T¸²ÇÁ¼¼Æ÷, B¸²ÇÁ¼¼Æ÷·Î ³ª´µ¾îÁö°Ô µÈ´Ù. T¸²ÇÁ¼¼Æ÷´Â ¼¼Æ÷¼º¸é¿ª¿¡ °ü¿©Çϸç, ÁַΠ¹ÙÀÌ·¯½ºº´¿¡ ´ëÇÑ ¸é¿ª±â´ÉÀ̳ª, ¾Ë·¹¸£±â(¸é¿ª¹ÝÀÀ 4¹øÇü µî) µî¿¡ °ü¿©ÇÑ´Ù. ÀÌ¿¡ ºñÇØ B¸²ÇÁ¼¼Æ÷´Â Ã¼¾×¼º¸é¿ª¿¡ °ü¿©ÇÏ¿©, Ç׿ø Ç×ü ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Ç×ü¸¦ »ý»êÇϰí ÁַΠ¼¼±Õ°¨¿°¿¡ ´ëÇÑ ¸é¿ª±â´ÉÀ» ´ã´çÇÑ´Ù.
¿µ¹® culture ÇÑ±Û ¹è¾ç
¼³¸í   
  ¹Ì»ý¹°À» ÀΰøÀû È¯°æÀ» Á¦°øÇÏ¿© ÀÚ¶ó°Ô Çϴ °ÍÀÌ´Ù. ¹è¾çƯ¡Àº »ê¼Ò°¡ ÀÖÀ¸¸é ´õ¿í Àß ÀÚ¶ó¸ç ¹è¾ç½Ã ÁÙ¸ð¾çÀ» Çü¼ºÇÔ. 10%ÀÇ ÀÌ»êȭź¼Ò¿¡ ÀÇÇØ ¼ºÀåÀÌ ÃËÁøµÈ´Ù.
¿µ¹® T-lymphocyte ÇÑ±Û Æ¼ ¸²ÇÁ±¸
¼³¸í   
  ¸²ÇÁ°è¼¼Æ÷(¸²ÇÁ±¸)´Â Å©°Ô 2°¡Áö·Î ´ëºÐµÈ´Ù. À̸¥¹Ù T¸²ÇÁ¼¼Æ÷(T-cell), B¸²ÇÁ¼¼Æ÷(B-cell)·Î ³ª´µ¾îÁø´Ù. T¸²ÇÁ¼¼Æ÷´Â ¼¼Æ÷¼º ¸é¿ª¿¡ °ü¿©Çϸç, ÁַΠ¹ÙÀÌ·¯½ºº´¿¡ ´ëÇÑ ¸é¿ª±â´ÉÀ̳ª, ¾Ë·¹¸£±â µî¿¡ °ü¿©ÇÑ´Ù. ÀÌ¿¡ ºñÇØ B¸²ÇÁ¼¼Æ÷´Â Ã¼¾×¼º ¸é¿ª¿¡ °ü¿©ÇÏ¿©, Ç׿ø Ç×ü ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Ç×ü¸¦ »ý»êÇϰí ÁַΠ¼¼±Õ¼º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ±â´ÉÀ» ´ã´çÇÑ´Ù. T-¸²ÇÁ±¸´Â ¸é¿ª±â´É¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» Çϴ ¼¼Æ÷·Î¼­ ¼¼Æ÷¸é¿ªÀ» ´ã´çÇϸç B-cellÀÇ ÀÛ¿ëÀ» Á¶ÀýÇϴ ±â´Éµµ ÀÖ´Ù. °ñ¼ö¿¡¼­ »ý¼ºµÇ¾î °¡½¿»ù¿¡¼­ ¼º¼÷µÈ´Ù. Å©°Ô º¸Á¶T¼¼Æ÷(helper T-cell: ¸é¿ªÀÛ¿ëÀÇ ¹ß»ýÀ» º¸Á¶ÇÑ´Ù)¿Í T¼¼Æ÷(suppressor T-cell: ¸é¿ªÀÛ¿ëÀÇ ¹ß»ýÀ» ¾ïÁ¦ÇÑ´Ù)·Î ±¸ºÐµÇ¸ç À̵éÀº ¼¼Æ÷ Ç¥¸é¿¡ ºÐÆ÷Çϴ Ç׿ø¿¡ ÀÇÇØ¼­ ½Äº°µÉ ¼ö ÀÖ´Ù.
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed culture
    ¼¯¾î½É±â, È¥ÇÕ¹è¾ç
  • mixed order reaction
    È¥ÇÕ¼ø¼­¹ÝÀÀ
  • atypical lymphocyte
    ºñÁ¤Çü¸²ÇÁ±¸
  • effector lymphocyte
    È¿°ú¸²ÇÁ±¸
  • killer lymphocyte
    »ìÇØ¸²ÇÁ±¸, ¼¼Æ÷µ¶¼º¸²ÇÁ±¸
  • lymphocyte
    ¸²ÇÁ±¸
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte inhibitory factor
    ¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
  • lymphocyte series
    ¸²ÇÁ±¸°è¿­
  • lymphocyte-activating determinant
    ¸²ÇÁ±¸È°¼º°áÁ¤ÀÎÀÚ
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
  • primed lymphocyte
    ÃÊȸ¹Î°¨¸²ÇÁ±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • lymphocyte
    ¸²ÇÁ±¸
  • culture
    1.¹è¾ç, ½É±â, 2.¹®È­
  • organ culture
    Àå±â¹è¾ç
  • quantitative culture
    Á¤·®¹è¾ç
  • tube culture
    ½ÃÇè°ü¹è¾ç
  • artificial culture medium
    Àΰø¹èÁö
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction
    ¹ÝÀÀ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed culture
    ¼¯¾î½É±â
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ
  • atypical lymphocyte
    ºñÀüÇü¸²ÇÁ±¸
  • lymphocyte-activating determinant
    ¸²ÇÁ±¸È°¼º°áÁ¤±â
  • effector lymphocyte
    ÀÛµ¿¸²ÇÁ±¸
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte inhibitory factor
    ¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
  • killer lymphocyte
    ¼¼Æ÷µ¶¼º¸²ÇÁ±¸
  • lymphocyte
    ¸²ÇÁ±¸
  • leukocytoid lymphocyte
    ¹éÇ÷±¸¸ð¾ç¸²ÇÁ±¸
  • lymphocyte series
    ¸²ÇÁ±¸°è¿­
  • primed lymphocyte
    ÃÊȸ¹Î°¨¸²ÇÁ±¸
  • resident lymphocyte
    »óÁÖ¸²ÇÁ±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • T cell ; T lymphocyte ; thymus derived lymphocyte
    T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
  • acute mixed-lineage leukmia
    ±Þ¼º È¥ÇÕÁ÷°è¼º ¹éÇ÷º´
  • amphiarthrosis =mixed joint
    ºÒÀüµ¿ °üÀý(ÝÕîïÔÑμï½), ¹Ý°üÀý(Úâμï½), ¿¬°ñ¼º ¿¬°á ºÎÀüµ¿ °üÀý, º¹ÇÕ°üÀý.
  • gallstone,mixed
    È¥ÇÕ(ûèùê)
  • gland, mixed salivary
    º¹ÇÕħ»ù, È¥ÇÕŸ¾×¼±
  • hearing loss, mixed
    È¥ÇÕ(¼º) ³­Ã»
  • hodgkins disease,mixed cellularity
    È¥ÇÕ¼¼Æ÷Çü
  • personality disorder, mixed type
    È¥ÀçÇü(ûèî¤úþ) ÀΰÝÀå¾Ö
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • aerobic culture
    È£±â¼º ¹è¾ç(¡­ÛÆå×).
  • agar culture
    ÇÑõ¹è¾ç(ùÎô¸ÛÆå×).
  • artificial culture medium
    Àΰø¹èÁö(ìÑÍïÛÆò¢).
  • hanging drop culture
    ÇöÀû¹è¾ç(¡­ÛÆå×).
  • plate culture
    ÆòÆÇ¹è¾ç(øÁ÷ùÛÆå×).
  • pour culture
    ºÎ¾î½É±â(ÆòÆÇ)¹è¾ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphocyte culture, mixed
    È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç(̴̰?Ë´ËÑËâ).
  • mixed lymphocyte culture
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç(¡­ûèùêÏ¹ÛÆå×).
  • mixed lymphocyte culture(MLC)
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸ È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte response(MLR)
  • mixed culture
    È¥ÇÕ¹è¾ç(ûèùêÛÆå×).
  • mixed lymphocytc culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • culture bottle =culture flask
    ¹è¾çº´ (¡­Üº).
  • leukocyte reaction, mixed
    È¥ÇÕ ¹éÇ÷±¸¹ÝÀÀ
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ(ûèùêó­ Úãëë).
  • pas reaction ; periodic acld schiff reaction
    PAS ¹ÝÀÀ<¿°»ö>(¡­Úãëë<æøßä>)
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ºÎÀÛ¿ë
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ¾àÇØ(å·úª)¹ÝÀÀ.[¾à¸®]ºÎÀÛ¿ë, ºÒ¿øÀÛ¿ë.
  • upgrading reaction => reversal reaction
    ¿ªÇà¹ÝÀÀ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Reaction deficiency
    ¹ÝÀÀ°áÇÌ
    [¿¾ ¿ë¾î] ¹ÝÀÀ°áÇÌ
  • Mixed type of artery
    È¥ÇÕÇüµ¿¸Æ
    [¿¾ ¿ë¾î] È¥ÇÕÇüµ¿¸Æ
  • Mixed nerve
    È¥ÇսŰæ
    [¿¾ ¿ë¾î] È¥ÇսŰæ
  • Small lymphocyte
    ÀÛÀº¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ¼ÒÀӯı¸
  • Large lymphocyte
    Å«¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ´ëÀӯı¸
  • Medium-sized lymphocyte
    Áß°£¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ÁßÀӯı¸
  • Lymphocyte
    ¸²ÇÁ±¸
    [¿¾ ¿ë¾î] Àӯı¸
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • filter paper slant culture
    ¿©°úÁö»ç¸é¹è¾ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte culture
    È¥ÇÕ(ûèùê)¸²ÆÄ±¸¹è¾ç(ÛÆå×)
  • mixed-order reaction
    È¥ÇÕ¼øÂ÷ ¹ÝÀÀ(ûèùêâ÷ó­Úãëë)
  • lymphocyte-derived chemotactic factor
    ¸²ÇÁ±¸-À¯µµ(ë¯Óô) È­ÇÐÁÖ¼ºÀÎÀÚ(ûùùÊñËà÷ì×í­)
  • lymphocyte transformation
    ¸²ÇÁ±¸º¯Çü(ܨû¡)
  • small lymphocyte
    ¼Ò(á³)Àӯı¸
  • T lymphocyte
    T Àӯı¸
  • mixed acid fermentation
    È¥ÇÕ»ê¹ßÈ¿(ûèùêۣ߫ý£)
  • mixed amino acid fermentation
    È¥ÇÕ(ûèùê)¾Æ¹Ì³ë»ê¹ßÈ¿(Û£ý£)
  • mixed anhydride
    È¥ÇÕ¹«¼ö¹°(ûèùêÙíâ©Úª)
  • mixed bed demineralizer
    È¥ÇÕ»óÅ»±¤¹°Áú±â(ûèùêßÒ÷­ÎÎÚªòõÐï)
  • mixed complex
    È¥¼ºº¹ÇÕ¹°(ûèà÷ÜÜùêÚª)
  • mixed function oxidase
    È¥ÇÕ±â´É(ûèùêѦÒö)¿Á½Ãµ¥À̽º
  • mixed indicator strain
    È¥¼º Áö½ÃÁÖ(ûèà÷ò¦ãÆñ»)
  • mixed inhibition
    È¥ÇÕÀúÇØ(ûèùêîÁúª)
  • mixed lactic fermentation
    È¥ÇÕÀ¯»ê¹ßÈ¿(ûèùêêáۣ߫ý£)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sputum culture
    ´ã¹è¾ç
  • tissue culture
    Á¶Á÷¹è¾ç
  • lymphocyte
    ¸²ÇÁ±¸
  • T cell ¡ìthymus derived lymphocyte¡í
    T¼¼Æ÷ ¡ì Èä¼±À¯·¡ ¸²ÇÁ±¸¡í
  • T lymphocyte
    T¸²ÇÁ±¸
  • mixed
    È¥ÇÕÇÑ, È¥¼ºÀÇ
  • mixed echo
    È¥ÇÕ¿¡ÄÚ, È¥Çո޾Ƹ®
  • mixed infection
    È¥ÇÕ°¨¿°
  • mixed pattern
    È¥ÇÕ¾ç»ó
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • adverse reaction
    ºÎÀÛ¿ë, À¯ÇعÝÀÀ, À¯ÇØÀÛ¿ë, ¿ª¹ÝÀÀ
  • antigen antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • desmoid reaction
    Àδë¾ç¹ÝÀÀ
  • glial reaction
    ±³¼¼Æ÷ÀÛ¿ë,½Å°æ±³ÀÛ¿ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MLC minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen...
MLTC mixed leukocyte-trophoblast culture; mixed lymphocyte tumor cell
LR labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l...
MLC   1) Minimal Lethal Concentration
  2) Mixed Lymphocyte Culture
AMLC adherent macrophage-like cell; autologous mixed lymphocyte culture
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MLR mixed lymphocyte culture reaction
MLC Mixed lymphocyte culture
MLTC mixed lymphocyte tumor culture
(MLR mixed lymphocyte culture
AMLR Autologous mixed lymphocyte reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mixed lymphocyte culture
    È¥ÇÕ ¸²ÇÁ±¸ ¹è¾ç
  • B lymphocyte
    B ¸²ÇÁ±¸
    1. Èä¼± ºñÀÇÁ¸¼ºÀ¸·Î Èä¼±ÀÇ ¿µÇâÀ» ¹ÞÁö ¾Ê°í, Á¶Á÷À» À¯ÁÖÇÏ´Â ¸²ÇÁ±¸. ü¾×¼º ¸é¿ª¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, Ç׿ø¿¡ ÀÇÇÑ ÀÚ±ØÀ¸·Î ¾×¼º Ç×ü¸¦ ÇÕ¼ºÇÏ´Â ÇüÁú±¸·Î µÈ´Ù. 2. Ç÷¾×, °ñ¼ö ¹× ¸²ÇÁÀý, ºñÀå, Æíµµ µî ¸²ÇÁÁ¶Á÷, ±×¸®°í ¼ÒÈ­°ü°è µîÀÇ ºñ¸²ÇÁ Á¶Á÷¿¡ ºÐÆ÷ÇÑ´Ù. ÀÎü Ç÷¾×ÀÇ 10-20% Â÷ÁöÇÑ´Ù. Ç׿ø µî¿¡ ÀÇÇØ Ȱ¼ºÈ­µÇ¸é ¸²ÇÁ¿©Æ÷ ³»¿¡¼­ ¸ð¼¼Æ÷ º¯È¯
  • B-lymphocyte
    B ¸²ÇÁ±¸
    Ç÷Áß Àӯı¸ÀÇ 5-15%¸¦ Â÷ÁöÇÏ¸ç ¼¼Æ÷ Ç¥¸é¿¡ ¸é¿ª ±Û·ÎºÎ¸°ÀÌ Á¸ÀçÇÑ´Ù. ÀÌµé ¸é¿ª ±Û·ÎºÎ¸°Àº Ç׿ø¿¡ ´ëÇÑ ¼ö¿ëü·Î ÀÛ¿ëÇÑ´Ù. Ç÷Áß B ¼¼Æ÷ÀÇ ´ëºÎºÐÀº Ç¥¸é¿¡ IgM°ú IgD¸¦ °®°í ÀÖÀ¸¸ç ¼Ò¼ö¿¡¼­ IgG, IgA ȤÀº IgE°¡ ¹ß°ßµÈ´Ù. ±×·¯³ª Á¡¸· µî¿¡¼­´Â IgA¸¦ °®°í ÀÖ´Â B¼¼Æ÷°¡ ¸¹ÀÌ ¹ß°ßµÈ´Ù.
  • bone marrow-derived lymphocyte
    °ñ¼ö À¯·¡ Àӯı¸
  • bursa-derived lymphocyte
    ÆÄºÎ¸®½Ã¿ì½º ³¶ À¯·¡ Àӯı¸
  • effector lymphocyte
    ÀÛµ¿ ¸²ÇÁ±¸
  • immunocompetent T lymphocyte
    ¸é¿ª Àû°Ý T Àӯı¸
  • lymphocyte
    Àӯı¸
  • lymphocyte defined antigen
    ¸²ÇÁ±¸ ±ÔÁ¤ Ç׿ø
  • lymphocyte migration
    Àӯı¸ À̵¿
  • marrow lymphocyte
    °ñ¼ö ¸²ÇÁ±¸
  • monocyte lymphocyte ratio
    ´Ü±¸ ¸²ÇÁ±¸ºñ
  • small lymphocyte
    ÀÛÀº ¸²ÇÁ±¸, ¼Ò¸²ÇÁ±¸
  • thymus-derived lymphocyte
    Èä¼± À¯·¡ Àӯı¸
  • agar culture
    ÇÑõ ¹è¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
lymphocyte lymphocyte A type of non-granular antibodies.
(09 Oct 1997)
mixed agglutination reaction Immune agglutination in which the aggregates contain cells of two different kinds but with common antigenic determinants; when used to identify isoantigens, the test cells are exposed to appropriate isoantibody, washed, and then mixed with indicator erythrocytes that combine with free sites on the test cell-attached isoantibody.
Synonym: mixed agglutination.
(05 Mar 2000)
malignant mixed mullerian tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
gonadal dysgenesis, mixed A syndrome of gonadal dysgenesis in which there is a testis on one side and a "streak gonad" on the other. The phenotype is generally male, but may be female since the individual is a mosaic. Various karyotypes have been identified, including 45,xo/47,xyy; 45,xo/46,xy; and 45,xo/46,xyo.
(12 Dec 1998)
mixed Formed by mixing; united; mingled; blended. See Mix, Mixed action, voices of both males and females united in the same performance.
Source: Websters Dictionary
(01 Mar 1998)
mixed agglutination Immune agglutination in which the aggregates contain cells of two different kinds but with common antigenic determinants; when used to identify isoantigens, the test cells are exposed to appropriate isoantibody, washed, and then mixed with indicator erythrocytes that combine with free sites on the test cell-attached isoantibody.
Synonym: mixed agglutination.
(05 Mar 2000)
mixed aphasia In which all aspects of speech and communication are severely impaired. at best, patients can understand or speak only a few words or phrases; they cannot read or write.
Synonym: mixed aphasia, total aphasia.
(05 Mar 2000)
mixed astigmatism Astigmatism in which one meridian is hyperopic while the one at right angle to it is myopic.
(05 Mar 2000)
mixed beat A beat triggered by more than a single electrical impulse, when the wave fronts coincide to act together on a single final pathway of activity; in the electrocardiogram, the atrial or ventricular complex when either atria or ventricles are activated jointly by two simultaneous or nearly simultaneous invading impulses.
Synonym: combination beat, mixed beat, summation beat.
(05 Mar 2000)
mixed cell leukaemia Term infrequently used as a designation for granulocytic leukaemia, thereby emphasizing the occurrence of different types of cells in the myeloid series (i.e., neutrophilic, eosinophilic, and basophilic granulocytes), in contrast to the comparatively monotonous pattern observed in lymphocytic and monocytic leukaemia.
(05 Mar 2000)
mixed chancre A sore resulting from simultaneous inoculation of a site with syphilis and chancroid.
(05 Mar 2000)
mixed connective tissue disease <syndrome> A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon.
The disease is differentially characterised by high serum titres of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen (nuclear ribonucleoprotein) and a speckled epidermal nuclear staining pattern on direct immunofluorescence.
A more modern term for this condition is the undifferentiated connective tissues disease.
(22 Sep 2002)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphocyte
    ¸²ÇÁÅç(¼¼Æ÷)
  • reaction
    ¹Ýµ¿
  • Feulgen reaction
    Æ÷ÀϰÕ(ÇÙ¿°»ö)¹ÝÀÀ
  • GVH reaction
    ´ë¼÷ÁÖ ÀÌ½ÄÆí ¹ÝÀÀ(ÀÌ½ÄµÈ Àå±â¿Í ü³» ¸é¿ª ¼¼Æ÷°£ÀÇ ¹ÝÀÀ)
  • atomic reaction
    ¿øÇÙ ¹ÝÀÀ
  • atonic reaction
    ¿øÀÚÇÙ¹ÝÀÀ
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • dark reaction
    (½Ä)¾Ï¹ÝÀÀ
  • exchange reaction
    (¹°)±³È¯ ¹ÝÀÀ
  • fightorfight reaction
    ¹æÀ§ ¹ÝÀÀÀÇ ÀÏÁ¾
  • fission chain reaction
    Çٺп­ ¿¬¼â ¹ÝÀÀ
  • fusion reaction
    ÇÙÀ¶ÇÕ ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • protective reaction
    ¹æ¾î ¹ÝÀÀ(ÀÚÀ§,º¸º¹À» ¸ñÀûÀ¸·Î ÇÑ Æø°Ý)
  • reaction
    ¹ÝÀÛ¿ë;¹ÝÇ×;¹Ý¹ß;(Á¤Ä¡»óÀÇ)¹Ýµ¿;¿ªÇà;(ÀÚ±Ø.»ç°Ç.¿µÇ⠵ ´ëÇÑ)¹ÝÀÀ;ŵµ;Àǰß;Àλó;(°ú·Î.±äÀå.ÈïºÐ ÈÄÀÇ)Ȱ·Â°¨Åð;¹«±â·Â;¹ÝÀÀ;¹ÝÀÛ¿ë;¹Ýµ¿·Â;ÇÙ¹ÝÀÀ;¹ÝÃæ ÀÛ¿ë;Àç»ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á